Acute pneumothorax due to immunotherapy administration in non-small cell lung cancer

Acute pneumothorax due to immunotherapy administration in non-small cell lung cancer

Nowadays we have novel therapies for advanced stage non-small cell lung cancer. Immunotherapy has been introduced in the market for several years and until now its administration is mostly based on the programmed death-ligand 1. First line treatment with immunotherapy can be administered alone if pr...

Full description

Bibliographic Details
Main Authors: Chrysanthi Sardeli, Paul Zarogoulidis, Konstantinos Romanidis, Panagoula Oikonomou, Konstantinos Sapalidis, Haidong Huang, Chong Bai, Wolfgang Hohenforst-Schmidt, Kosmas Tsakiridis, Bojan Zaric, Branislav Perin, Aris Ioannidis, Sofia Baka, Konstantinos Drevelegas, Maria Kosmidou, Christoforos Kosmidis
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Immunotherapy
Non-small cell lung cancer
Pneumothorax
Pembrolizumab
EBUS
Online Access:http://www.sciencedirect.com/science/article/pii/S221300712030472X

Internet

http://www.sciencedirect.com/science/article/pii/S221300712030472X

Similar Items